MedTrace Logo

ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

NCT05787197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 232

Last updated 2025-07-23

No results posted yet for this study

Summary

This is a prospective multicenter cohort study, was designed to explore the prognostic value of ctDNA as a biomarker of disease response and recurrence or death in patients undergoing curative-intent surgical resection of Colorectal cancer liver metastasis.

Conditions

Sponsors & Collaborators

  • GERCOR - Multidisciplinary Oncology Cooperative Group

    lead OTHER

Principal Investigators

  • Maximiliano GELLI, MD · Department of Digestive Surgery, Gustave Roussy Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-09
Primary Completion
2025-09-25
Completion
2027-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05787197 on ClinicalTrials.gov